You are here: Industry Insights > COVID-19

News List

Researcher claims antiviral medicine for cats also works against COVID-19 expresspharma
August 31, 2020
The scientists said they plan to test modifications of the drug to make it an even better fit inside the virus.
Search for COVID-19 drugs boosted by SARS discovery worldpharmanews
August 28, 2020
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.
NIHR, UKRI stream ￡8.4m into coronavirus studies pharmatimes
August 28, 2020
NIHR and UK Research and Innovation (UKRI) are streaming ￡8.4 million into three new UK-wide research studies aiming to understand immune responses to the novel coronavirus.
New York Blood Center Research Confirms Effectiveness of Rapid Serological Test for COVID-19 americanpharmaceuticalreview
August 28, 2020
The New York Blood Center Lindsley F. Kimball Research Institute announced the results of an independent study that showed the Clungene? SARS-CoV-2 Virus (COVID-19) IgG/IgM Rapid Test Cassette possesses a high degree of sensitivity and specificity for ...
Tyme’s Oncology Research Identifies Potential New Oral Therapy TYME-19 for COVID-19 americanpharmaceuticalreview
August 28, 2020
Tyme Technologies announced a potential new approach to treating COVID-19 using a metabolic agent, TYME-19.
JanOne Advances Potential Peripheral Artery Disease, COVID-19 Vascular Inflammation Treatment americanpharmaceuticalreview
August 28, 2020
JanOne has successfully completed its initial engineering batch of JAN101.
Laurent Pharma Initiates Phase II Trial of LAU-7b in COVID-19 Disease contractpharma
August 28, 2020
LAU-7b has shown potent antiviral effects against SARS-CoV-2 and MERS-CoV coronaviruses, and is also being developed for its anti-inflammatory properties.
Vaccitech Receives UK Grant to Support COVID-19 Tech Platform contractpharma
August 28, 2020
Vaccitech's new platform induces leading antibody and cell-mediated immune responses, two arms of the immune system known to protect against disease.
India’s proposed new agile pharma regulations will benefit innovator companies: GlobalData expresspharma
August 28, 2020
This could mean accelerated access of multiple novel therapies and vaccines for Indian patients.
Europe's largest initiative launches to accelerate therapy development for COVID-19 and future coronavirus threats worldpharmanews
August 27, 2020
CARE (Corona Accelerated R&D in Europe) a new consortium supported by the Innovative Medicines Initiative (IMI) public-private partnership announced its launch to accelerate the discovery and development of urgently needed medicines to treat SARS-CoV-2...